Xerostomia is one of the most likely late toxic effects of radiotherapy treatment in patients with head-and-neck cancers. Modern treatment techniques can incorporate knowledge of complication risk into treatment plans. To this end, the authors attempt to quantify the regional radiotherapy dose-dependence of salivary output loss and recovery in a prospective study.
Salivary output was collected from patients undergoing radiotherapy treatment for head-and-neck cancers at the BC Cancer Agency between February 2008 and May 2013. Regional dose-dependence (i.e., dose susceptibility) of loss and recovery is quantified using nonparametric (Spearman's rank correlation coefficients, local linear regression) and parametric (least-sum of squares, least-median of squares) techniques.
Salivary flow recovery was seen in 79 of 102 patients considered (p < 0.0001, Wilcoxon sign rank test). Output loss was strongly correlated with left- and right parotid combined dose φ = min (DL, 45 Gy) + min (DR, 45 Gy), and can be accurately predicted. Median early loss (three months) was 72% of baseline, while median overall loss (1 yr) was 56% of baseline. Fitting an exponential model to whole parotid yields dose sensitivities A3m = 0.0604 Gy−1 and A1y = 0.0379 Gy−1. Recovery was not significantly associated with dose. Hints of lateral organ sub-segment dose–response dimorphism were observed.
Sub-segmentation appears to predict neither loss nor recovery with any greater precision than whole parotid mean dose, though it is not any worse. Sparing the parotid to a combined dose φ of <50 Gy is recommended for a patient to keep ≈40% of baseline function and thus avoid severe xerostomia at 12 months post-treatment. It seems unlikely that a population's mean recovery will exceed 20%–30% of baseline output at 1 yr after radiotherapy treatment using current (whole-organ based) clinical guidelines.
- 1 et al., “Parotid gland function during and following radiotherapy of malignancies in the head and neck: A consecutive study of salivary flow and patient discomfort,” Eur. J. Cancer 28, 457–462 (1992).10.1016/s0959-8049(05)80076-0
- 2 et al., “Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study,” Int. J. Radiat. Oncol., Biol., Phys. 57, 61–70 (2003).10.1016/s0360-3016(03)00361-4
- 3 et al., “Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): Evidence from a prospective randomized study,” Oral Oncol. 49(6), 634–642 (2013).10.1016/j.oraloncology.2013.02.013
- 4 et al., “Dose–volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 62, 1055–1069 (2005).10.1016/j.ijrobp.2004.12.076
- 5 et al., “Novel approaches to improve the therapeutic index of head and neck radiotherapy: An analysis of data from the PARSPORT randomised phase III trial,” Radiother. Oncol. 103(1), 82–87 (2012).10.1016/j.radonc.2012.02.006
- 6 et al., “Xerostomia and its predictors following parotidsparing irradiation of head-and-neck cancer,” Int. J. Radiat. Oncol., Biol., Phys. 50, 695–704 (2001).10.1016/s0360-3016(01)01512-7
- 7 et al., “The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 67(3), 660–669 (2007).10.1016/j.ijrobp.2006.09.021
- 8 et al., “A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results,” Int. J. Radiat. Oncol., Biol., Phys. 49, 907–916 (2001).10.1016/s0360-3016(00)01441-3
- 9 et al., “Semi-automated contour recognition using DICOMautomaton,” J. Phys.: Conf. Ser. 489(1), 012088 (2014).10.1088/1742-6596/489/1/012088
- 10 et al., “Automated segmentation and dose-volume analysis with DICOMautomaton,” J. Phys.: Conf. Ser. 489(1), 012009 (2014).10.1088/1742-6596/489/1/012009
- 11, Handbook of Parametric and Nonparametric Statistical Procedures (CRC, New York, 2003).
- 12, All of Nonparametric Statistics, 4th ed. (Springer, New York, 2006).
- 13 and , “Likelihood-based local linear estimation of the conditional variance function,” J. Am. Stat. Assoc. 99, 139–144 (2004).10.1198/016214504000000133
- 14 and , “A simplex method for function minimization,” Comput. J. 7, 308–313 (1965).10.1093/comjnl/7.4.308
- 15, “The proof and measurement of association between two things,” Am. J. Psychol. 15, 72–101 (1904).10.2307/1412159
- 16, “Kendall's and Spearman's correlation coefficients in the presence of a blocking variable,” Biometrics 43, 409–416 (1987).10.2307/2531822
- 17, , and , “Power of the Mann–Kendall and Spearman's rho tests for detecting monotonic trends in hydrological series,” J. Hydrol. 259, 254–271 (2002).10.1016/s0022-1694(01)00594-7
- 18 et al., “Multivariable modeling of radiotherapy outcomes, including dose–volume and clinical factors,” Int. J. Radiat. Oncology., Biol., Phys. 64, 1275–1286 (2006).10.1016/j.ijrobp.2005.11.022
- 19 et al., “Radiotherapy dose–volume effects on salivary gland function,” Int. J. Radiat. Oncology., Biol., Phys. 76, S58–S63 (2010).10.1016/j.ijrobp.2009.06.090
- 20 and , “Least median of squares: A suitable objective function for stock assessment models?,” Can. J. Fish. Aquat. Sci. 59, 1474–1481 (2002).10.1139/f02-112
- 21, “Bootstrap methods: Another look at the jackknife,” Ann. Stat. 7, 1–26 (1979).10.1214/aos/1176344552
- 22 et al., “Variability of flow rate when collecting stimulated human parotid saliva,” Eur. J. Oral Sci. 113, 386–390 (2005).10.1111/j.1600-0722.2005.00241.x
- 23 and , “Low unstimulated salivary flow and subjective oral dryness: Association with medication, anxiety, depression, and stress,” J. Dent. Res. 79, 1652–1658 (2000).10.1177/00220345000790090301
- 24 et al., “Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 74, 1002–1005 (2009).10.1016/j.ijrobp.2009.03.039
- 25 et al., “Using a Bayesian feature-selection algorithm to identify dose–response models based on the shape of the 3D dose-distribution: An example from a head-and-neck cancer trial,” in Ninth International Conference on Machine Learning and Applications (ICMLA) (IEEE, Washington, DC, 2010), pp. 740–745.